Trellis Bioscience

company

About

Trellis Bioscience is a therapeutic antibody company developing treatments for infectious diseases and oncology indications.

  • San Francisco,California,United States
  • 51 - 100

Details

Last Funding Type
Series B
Last Funding Money Raised
$10M
Industries
Biotechnology,Health Care,Therapeutics
Founded date
Jan 1, 1998
Number Of Employee
51 - 100
Operating Status
Active

Trellis Bioscience develops a technology platform for cellular informatics. The company's technology has applications in the discovery and production of therapeutic monoclonal antibodies. Its cell biology platform provides a direct readout at the single cell level for monitoring activity of diverse cell types and quantifying the impact of potential therapeutic interventions. The company is based in San Francisco, California.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
5
$28.57M
Trellis Bioscience has raised a total of $28.57M in funding over 2 rounds. Their latest funding was raised on Oct 1, 2019 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 1, 2019 Grant $3.20M 1 CARB-X Detail
Nov 9, 2011 Debt Financing $235K Detail
Aug 7, 2009 Series Unknown $11.71M Detail
Feb 14, 2007 Series B $10M 4 Novartis Venture Fund Detail
Jan 2, 2004 Series A $3.42M Detail

Investments

Number of Investments
Number of Lead Investments
1
0
Trellis Bioscience has made 1 investments. Their most recent investment was on May 24, 2006, when Promedior raised $14M.
Date Company Name
Round Money Raised Industry Lead Investor
May 24, 2006 Promedior
Series A $14M Biopharma

Investors

Number of Lead Investors
Number of Investors
2
5
Trellis Bioscience is funded by 5 investors. CARB-X and Novartis Venture Fund are the most recent investors.
Investor Name Lead Investor Funding Round
CARB-X Yes Grant
Novartis Venture Fund Yes Series B
Easton Capital Series B
Morgenthaler Ventures Series B
Pac-Link Series B

Employee Profiles

Number of Employee Profiles
6
Trellis Bioscience has 6 current employee profiles, including Board member Jack M. Anthony
Board member
Board member
Executive
Executive
Employee

Exits

Trellis Bioscience has had 1 exits. Trellis Bioscience most notable exits include Promedior

Date Company Name Exit Type Industry
Nov 15, 2019 Promedior M&A Biopharma Detail